Ovarian maintenance compositions and uses thereof
By compounding equadol, ergothioneine and disodium pyrroloquinoline quinone in the ovarian care composition, the problems of low bioavailability and insufficient synergistic effect in existing ovarian health products have been solved, and significant improvement in ovarian function and care effect has been achieved.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- BLOOMAGE BIOTECHNOLOGY CORP LTD
- Filing Date
- 2026-06-10
- Publication Date
- 2026-07-17
AI Technical Summary
Existing ovarian health products mostly use a single active ingredient, which has problems such as low bioavailability and insufficient synergistic effect, and cannot effectively improve ovarian function, thus affecting women's fertility and quality of life.
An ovarian care composition is provided, comprising equadol, ergothioneine and disodium pyrroloquinoline quinone, which are compounded in a specific ratio to form a multi-target, multi-mechanism synergistic oral composition, thereby improving absorption and enhancing efficacy.
By combining equadol, ergothioneine, and disodium pyrroloquinoline quinone, the levels of anti-Müller hormones are significantly increased, ovarian function is improved, and the effect of nourishing the ovaries and enhancing women's ovarian reserve is achieved.
Smart Images
Figure SMS_1 
Figure SMS_2 
Figure SMS_3